Medication info
Twincombi Tablets 40/10mg

Twincombi Tablets 40/10mg

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to slightly yellow and light blue, double convex oval tablets.
Packaging
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201606306 · Approved 2016.10.27 · Insurance code 671806380

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan); however, if blood pressure is not adequately controlled with an individual component as follows, switching directly to this drug may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this drug 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who do not have sufficient blood pressure control with monotherapy of amlodipine or telmisartan. It helps to manage blood pressure more effectively by combining both medications. This contributes to stabilizing blood pressure and reducing the risk of cardiovascular complications. It is used to improve the patient's blood pressure control status.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan); however, if blood pressure is not adequately controlled with an individual component as follows, switching directly to this drug may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this drug 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dosage adjustment is needed in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 milligrams. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain diseases or drug allergies, severe liver impairment or cardiac issues, and certain kidney diseases. Patients with impaired liver function, gastrointestinal diseases, renal artery hypertension, elderly patients, and others should use this medication with special caution. Taking this medication may commonly result in side effects such as dizziness or swelling, and serious side effects may rarely occur. Patients should consult medical professionals immediately if any abnormal symptoms appear. During treatment, there is a risk of hypotension, hyperkalemia, and changes in kidney function, hence regular monitoring of blood pressure and blood tests is necessary. This medication can interact with other drugs, so if you are taking any other medications, be sure to inform your doctor or pharmacist. Use of this medication should be avoided during pregnancy or breastfeeding, and it should be discontinued immediately if pregnancy is confirmed. The safety and efficacy of this medication in children or adolescents under the age of 18 have not been sufficiently established, and it is not recommended. In elderly patients, doses should be adjusted and used with caution, and overdose may result in severe hypotension or cardiac function deterioration requiring immediate emergency treatment. Keep this medication out of the reach of children and store it in its original packaging to maintain safety.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • indigestion
  • nausea
  • vomiting
  • dry mouth
  • gingival enlargement
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic dermatitis
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container to protect it from light and air. Additionally, it is important to maintain a cool room temperature, between 1 degree and 30 degrees Celsius, when storing the medication. This will help to preserve the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White to slightly yellow and light blue, double convex oval tablets.

Package unit

30 tablets (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.